Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 2
2014 1
2017 2
2018 1
2019 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.
Dierickx LO, Huyghe E, Nogueira D, Zerdoud S, Filleron T, Brillouet S, Delauney B, Montagut J, Bujan L, Plante P, Courbon F. Dierickx LO, et al. Among authors: brillouet s. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):129-37. doi: 10.1007/s00259-011-1929-3. Epub 2011 Sep 10. Eur J Nucl Med Mol Imaging. 2012. PMID: 21909754
The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Bauriaud-Mallet M, Vija-Racaru L, Brillouet S, Mallinger A, de Medina P, Rives A, Payre B, Poirot M, Courbon F, Silvente-Poirot S. Bauriaud-Mallet M, et al. Among authors: brillouet s. J Steroid Biochem Mol Biol. 2019 Sep;192:105390. doi: 10.1016/j.jsbmb.2019.105390. Epub 2019 Jun 3. J Steroid Biochem Mol Biol. 2019. PMID: 31170473
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
Vija Racaru L, Sinigaglia M, Kanoun S, Ben Bouallègue F, Tal I, Brillouet S, Bauriaud-Mallet M, Zerdoud S, Dierickx L, Vallot D, Caselles O, Gabiache E, Pascal P, Courbon F. Vija Racaru L, et al. Among authors: brillouet s. Nucl Med Commun. 2018 Jul;39(7):672-679. doi: 10.1097/MNM.0000000000000850. Nucl Med Commun. 2018. PMID: 29790867 Free PMC article.
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.
Vija Racaru L, Fontan C, Bauriaud-Mallet M, Brillouet S, Caselles O, Zerdoud S, Bastié D, Vallot D, Caron P, Bardiès M, Courbon F. Vija Racaru L, et al. Among authors: brillouet s. Nucl Med Commun. 2017 Sep;38(9):756-763. doi: 10.1097/MNM.0000000000000705. Nucl Med Commun. 2017. PMID: 28719405 Clinical Trial.
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
Vergez S, Delord JP, Thomas F, Rochaix P, Caselles O, Filleron T, Brillouet S, Canal P, Courbon F, Allal BC. Vergez S, et al. Among authors: brillouet s. Clin Cancer Res. 2010 Sep 1;16(17):4434-45. doi: 10.1158/1078-0432.CCR-09-2795. Epub 2010 Jul 26. Clin Cancer Res. 2010. PMID: 20660574
11 results